Drug Patents owned by Hisamitsu

1. Drug name - SECUADO

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10583121 HISAMITSU Patch Jul, 2033

(10 years from now)

US10814002 HISAMITSU Patch and method for producing the same Jul, 2033

(10 years from now)

US9687474 HISAMITSU Patch Jul, 2033

(10 years from now)

US10022445 HISAMITSU Patch Jul, 2033

(10 years from now)

US11123305 HISAMITSU Patch Jul, 2033

(10 years from now)

Drugs and Companies using ASENAPINE ingredient

Treatment: Method of treating adults with schizophrenia comprising administering asenapine via a transdermal patch

Dosage: SYSTEM;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
3.8MG/24HR SYSTEM;TRANSDERMAL Prescription
5.7MG/24HR SYSTEM;TRANSDERMAL Prescription
7.6MG/24HR SYSTEM;TRANSDERMAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.